Literature DB >> 18641280

Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium.

Qian Garrett1, Shunjiang Xu, Peter A Simmons, Joseph Vehige, Judith L Flanagan, Mark D Willcox.   

Abstract

PURPOSE: The existence of an organic cation transport process in rabbit cornea and conjunctiva that mediates absorption of carnitine has previously been suggested. This study was conducted to determine the expression and localization of the carnitine/organic cation transporter (OCTN1 and OCTN2) in corneal or conjunctival epithelium.
METHODS: Reverse transcriptase-polymerase chain reaction (RT-PCR) was used for OCTN1 and OCTN2 mRNA expression in cultured human corneal-limbal epithelial (HCLE) or human conjunctival epithelial (HCjE) cells. Immunofluorescence staining with polyclonal antibody against human OCTN1 or OCTN2 was performed to investigate transporter expression in ocular epithelial cells or rabbit corneal and conjunctival epithelium. Polarity of the transporter expression was determined using Western blot analysis of the apical or basal membrane proteins extracted from the cultured cells. Apical or basal uptake of [H(3)]-L-carnitine was determined using the polarized epithelial cells grown onto collagen-coated porous filter support.
RESULTS: OCTN1 and OCTN2 mRNA expression was detected in HCLE and HCjE cells of rabbits and humans. OCTN1 and OCTN2 were predominately localized in the apical membranes of the cells. HCLE and HCjE cells were able to take up L-carnitine; most carnitine uptake occurred through the apical surfaces.
CONCLUSIONS: This report is the first to document OCTN1 and OCTN2 expression in human corneal and conjunctival epithelial cells. These findings suggest potential involvement of OCTN1 and OCTN2 in the transport of carnitine in ocular tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641280     DOI: 10.1167/iovs.07-1528

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.

Authors:  Rajendra S Kadam; Sunil K Vooturi; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2012-11-20       Impact factor: 3.922

2.  Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress.

Authors:  Xia Hua; Zhitao Su; Ruzhi Deng; Jing Lin; De-Quan Li; Stephen C Pflugfelder
Journal:  Curr Eye Res       Date:  2014-10-01       Impact factor: 2.424

3.  Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial Cells.

Authors:  Xia Hua; Ruzhi Deng; Jin Li; Wei Chi; Zhitao Su; Jing Lin; Stephen C Pflugfelder; De-Quan Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

4.  Role of carnitine in disease.

Authors:  Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark Dp Willcox; Qian Garrett
Journal:  Nutr Metab (Lond)       Date:  2010-04-16       Impact factor: 4.169

5.  Potential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically.

Authors:  J Nirmal; S B Singh; N R Biswas; V Thavaraj; R V Azad; T Velpandian
Journal:  Eye (Lond)       Date:  2013-07-12       Impact factor: 3.775

Review 6.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

7.  Transport of L-carnitine in human corneal and conjunctival epithelial cells.

Authors:  Shunjiang Xu; Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark D Willcox; Qian Garrett
Journal:  Mol Vis       Date:  2010-09-04       Impact factor: 2.367

8.  Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro.

Authors:  Rui Zhang; Hong Zhang; Zhongxia Zhang; Tao Wang; Jingya Niu; Dongsheng Cui; Shunjiang Xu
Journal:  Int J Mol Sci       Date:  2012-02-15       Impact factor: 6.208

Review 9.  Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease.

Authors:  Antonio José Mateo Orobia; Jorge Saa; Alberto Ollero Lorenzo; José María Herreras
Journal:  Clin Ophthalmol       Date:  2018-03-06

10.  Decrease in hyperosmotic stress-induced corneal epithelial cell apoptosis by L-carnitine.

Authors:  Neeta Khandekar; Mark D P Willcox; Sharon Shih; Peter Simmons; Joseph Vehige; Qian Garrett
Journal:  Mol Vis       Date:  2013-09-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.